跳至主要内容
临床试验/IRCT2015060222540N1
IRCT2015060222540N1已完成未知

Evaluation of vasopressin nasal spray effect on the amount of hypertonic saline required for the treatment of intradialytic hypotension in End-stage renal disease patients

All costs of this study were be paid by the researcher0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 70 years(—)
性别
All

入选标准

  • ESRD patients with known symptomatic episode of intradialytic hypotension in at least 30% of hemodialysis sessions in the 30 days preceding enrollment; Serum sodium levels greater than 140 mEq/L.
  • Exclusion criteria: History of ischemic heart desease; History of cardiovascular events (MI, CVA, ...); Anemia (HB<10 g/dL); Usage of other treatments for intradialytic hypotension at the same time

排除标准

  • 未提供

研究者

发起方
All costs of this study were be paid by the researcher

相似试验